The Short Answer
There Is No Dose Conversion
Zepbound® contains tirzepatide and Wegovy® contains semaglutide, so their milligram amounts do not line up. No official chart converts one to the other, and your prescriber sets your Wegovy® dose.
Each Label Covers Only Its Own Medicine
The Wegovy® label explains its own steps for people starting it, and the Zepbound® label does the same. Neither label gives instructions for moving from the other brand.
They Are Not Taken Together
Both labels say combining the medicine with any other GLP-1 receptor agonist is not recommended. Your prescriber will tell you how to stop one and start the other.
A Good Record Makes the Switch Easier
Doses, side effects, meals and weight logged through the change show your prescriber how it is going. Small details, like which day a symptom started, are easy to forget without them.
What Changes When You Move From Tirzepatide to Semaglutide
From the Zepbound® and Wegovy® prescribing information.
| Zepbound® | Wegovy® | |
|---|---|---|
| Ingredient | Tirzepatide | Semaglutide |
| Maker | Eli Lilly | Novo Nordisk |
| Receptors | GIP and GLP-1 | GLP-1 |
| Form | Once-weekly injection | Once-weekly injection or once-daily tablet |
| Approved uses | Weight reduction; obstructive sleep apnea in adults with obesity | Weight reduction; heart risk reduction; MASH (injection) |
A Different Ingredient and Maker
Zepbound® is tirzepatide from Eli Lilly, and Wegovy® is semaglutide from Novo Nordisk. Pep AI is not affiliated with either company, and the facts here come from the public FDA labels.
One Receptor Instead of Two
Tirzepatide acts on both the GIP and GLP-1 receptors, while semaglutide acts on the GLP-1 receptor. Both work through gut hormone pathways involved in appetite and blood sugar.
Shot or Daily Tablet
Zepbound® is a once-weekly injection, and Wegovy® comes as a once-weekly injection or a once-daily tablet. Your prescriber chooses the form, and each form has its own instructions on the label.
Approved Uses That Overlap
Both labels include long-term weight reduction in adults with obesity, or overweight with a weight-related condition. Wegovy® also covers heart event risk reduction and MASH, while Zepbound® also covers obstructive sleep apnea in adults with obesity. The full Wegovy® vs Zepbound® comparison sets both labels side by side.
What Each Label Says About Its Own Starting Step
Each label lists a starting step for people beginning that medicine for the first time. These are quoted as each label's own schedule for new users. They are not a switching plan and not a dose for you.
The Wegovy® Label
For people starting Wegovy® injection, the label's schedule lists 0.25 mg once weekly as the first step, rising in 4-week stages. For people starting Wegovy® tablets, it lists 1.5 mg once daily as the first step.
The Zepbound® Label
For people starting Zepbound®, the label's schedule lists 2.5 mg once weekly as the first step, rising in 2.5 mg stages. Those numbers describe Zepbound® only and do not carry over to Wegovy®.
What the Labels Do Not Say
Neither label says where someone coming from Zepbound® should begin on Wegovy®. That decision is your prescriber's, based on your history and how you have been feeling.
Why the Milligram Numbers Can't Be Compared
The molecules are different, so milligram amounts of one say nothing about the other.
What to Track Through the Switch
You cannot control the plan, but you can control the record.
Every Dose, Exactly as Prescribed
Log the date of your last Zepbound® dose and each Wegovy® dose as you take it. When a question comes up later, the dates are already there.
Side Effects, With Timing and Severity
Pep AI's side-effect log has a built-in list of GLP-1 symptoms, plus your own, each rated for severity on the day you log it. Comparing those days with your dose dates makes the conversation with your prescriber much clearer.
Food, Protein and Water
Appetite can shift during a change, so Pep AI keeps protein, fiber and water front and center. Meals logged by photo scan, barcode, restaurant menu scan or search sit in the same app as your doses. More in the GLP-1 food tracker.
Weight on One Continuous Line
Pep AI keeps one weight trend across both medicines, along with progress photos. Weight can sync from Apple Health on iPhone or Health Connect on Android, so the line keeps going without extra typing.
Side Effects to Watch on Wegovy®
From the weight-reduction trials on the Wegovy® label, each read against placebo.
| Side effect | Wegovy® 2.4 mg | Placebo |
|---|---|---|
| Nausea | 44% | 16% |
| Diarrhea | 30% | 16% |
| Vomiting | 24% | 6% |
| Constipation | 24% | 11% |
| Stomach pain | 20% | 10% |
Common Effects on the Wegovy® Label
In weight-reduction trials of Wegovy® 2.4 mg, nausea affected 44% of people compared with 16% on placebo, and diarrhea, vomiting and constipation were also common. The label says to step up gradually to lower the risk of stomach side effects.
Effects You May Already Know
Zepbound® lists many of the same stomach effects, but the Wegovy® label stands on its own and nobody can predict how you will feel. Track what happens rather than assuming it will match your Zepbound® weeks.
Signs That Need Medical Attention
Severe stomach pain that will not go away, signs of an allergic reaction, or vomiting and diarrhea that cause dehydration need prompt care.
The Boxed Warning on Both Labels
Both labels carry a boxed warning because the active ingredient caused thyroid C-cell tumors in rodents, and it is unknown whether this happens in people. Neither should be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or with multiple endocrine neoplasia syndrome type 2 (MEN 2). Report a lump or swelling in the neck, trouble swallowing, hoarseness or shortness of breath.
Full Guides for Both Medicines
The GLP-1 side effects guide covers the Wegovy® and Zepbound® tables side by side, and side effects by week covers when they tend to show up.
Questions to Ask Your Prescriber
A switch goes better when you know what to ask.
About the Plan
Ask when to take your last Zepbound® dose, when to take your first Wegovy® dose and which step you will start on. Write the answers down or add them to your schedule in the app.
About Side Effects
Ask which symptoms to expect, which ones mean you should call, and what to do if a step feels hard. Ask how they want you to report how you are feeling between visits.
About Your Other Medicines
Mention every medicine you take, since both labels warn about low blood sugar with insulin or a sulfonylurea. Semaglutide also slows stomach emptying, which can change how some pills are absorbed.
Bring a Report to the Visit
Pep AI turns your doses, injection sites, weight and daily meal totals into a PDF report you can share with your prescriber. Your prescriber sees your doses and weight across the switch instead of piecing them together from memory.
Set Up Wegovy® in Pep AI
Your history survives the switch.
Add the New Medicine
Add Wegovy® as a new medication in Pep AI with the schedule and step your prescriber gave you. Each medicine keeps its own schedule and history, so your Zepbound® entries stay where they are. See the Wegovy® tracker.
Move Your Reminders
Pep AI reminds you on shot day, or every day if you take Wegovy® tablets. On iPhone, home-screen widgets, a Lock Screen Live Activity and an Apple Watch app show what is due at a glance.
Keep Rotating Sites
For Wegovy® injections, the Pep AI body map shows where your recent shots went. Rotating sites with each dose is what both injection labels ask for; more in injection site rotation.
Key takeaways
- There is no dose conversion between Zepbound® and Wegovy®, and neither label covers moving from the other brand.
- Your prescriber decides when you stop, when you start and which Wegovy® step you start on.
- Milligram amounts of different molecules can't be compared.
- The two are not taken together, and both carry the thyroid C-cell tumor boxed warning.
- Log every dose, symptom, meal and weight through the change, and bring the PDF report of your doses and weight to your next visit.
Whatever your prescriber decides, keep the record.
Doses, side effects, meals and weight for any GLP-1 brand, in one app. Pep AI is free to try on iPhone and Android: a free download with a 3-day free trial, then a subscription.
Frequently asked questions
Keep reading
Sources
This guide is general information based on FDA prescribing information. It is not medical advice and does not give doses, conversions or timing. Only your prescriber can plan a switch, including when to stop one medicine, when to start the other and which step you start on. Dose steps quoted here are each label's own schedule for new users, not a switching plan. Pep AI is not affiliated with Novo Nordisk or Eli Lilly, and brand names are trademarks of their owners. If a symptom is severe or worrying you, contact your healthcare provider. In an emergency, call 911.
Published by the Pep AI team · Updated November 2026